A case report of allergic blepharoconjunctivis to alcaftadine

نویسنده

  • Leda Das Neves Almeida Sandrin
چکیده

Results A 32-year-old Brazilian woman presented with chronic pruritic eyes for three years and recurrent episodes of eyelid inflammation during the last six months in an ophthalmology practice. The clinical finds were conjunctival hyperemia and edema of the eyelids. The hypothesis of perennial allergic conjunctivitis was done and the use of alcaftadine eye drops once a day was prescribed. She returned after two weeks and the worsening of the symptoms was related. She was advised to visit an allergist and to stop the use of alcaftadine. At that time she had edema and erythema of both eyelids. Allergic contact blepharoconjunctivitis was suspected and standardized patch test as well as products she was using on the face, on the hair and over the eyes were tested. Alcaftadine (+++48h/ +++96h), hidroquinone (+++48h/+++96h), fragrance mix (++48h/+96h), triethanolamine (++48h/+96h), shampoo (+++48h/+++96h) were positive. Benzalkonium chloride, a preservative found in alcaftadine, was negative. SPT to grass pollen and house dust mites were positive. Avoidance of alcaftadine and shampoo, use of preservative free eye lubricants, nasal corticosteroids and environmental control had completely cleared the symptoms.

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Update and clinical utility of alcaftadine ophthalmic solution 0.25% in the treatment of allergic conjunctivitis

Allergic disorders of the ocular surface are primarily characterized as IgE- and/or T-lymphocyte-mediated disorders that affect the cornea, conjunctiva, and eyelid. Approximately 40% of individuals in the developed countries have allergic conjunctivitis, and as such, it is the most common form of ocular allergy. Seasonal allergic conjunctivitis is the most prevalent type of allergic conjunctivi...

متن کامل

Comparison of effects of alcaftadine and olopatadine on conjunctival epithelium and eosinophil recruitment in a murine model of allergic conjunctivitis

BACKGROUND Antihistamines constitute the first line of therapy for allergic conjunctivitis, and are safe and effective in relieving the signs and symptoms of ocular allergy. Despite this, they are less effective than some other drugs in relieving delayed symptoms of allergic conjunctivitis. Recent evidence suggests that changes in the conjunctival epithelium may underlie aspects of delayed reac...

متن کامل

Ocular Itch Relief with Alcaftadine 0.25% Versus Olopatadine 0.2% in Allergic Conjunctivitis: Pooled Analysis of Two Multicenter Randomized Clinical Trials

INTRODUCTION The efficacy and safety of the once-daily topical ophthalmic solutions, alcaftadine 0.25% and olopatadine 0.2%, in preventing ocular itching associated with allergic conjunctivitis were evaluated. METHODS Pooled analysis was conducted of two double-masked, multicenter, active- and placebo-controlled studies using the conjunctival allergen challenge (CAC) model of allergic conjunc...

متن کامل

Effect of alcaftadine 0.25% on ocular itch associated with seasonal or perennial allergic conjunctivitis: a pooled analysis of two multicenter randomized clinical trials

PURPOSE Seasonal and perennial allergic conjunctivitis represent the majority of cases of ocular allergy. This analysis was designed to evaluate the efficacy and safety of once-daily alcaftadine 0.25% in preventing ocular itching associated with seasonal or perennial allergic conjunctivitis. SUBJECTS AND METHODS Pooled data from two double-masked, multicenter, placebo-controlled studies using...

متن کامل

Evaluation of alcaftadine 0.25% ophthalmic solution in acute allergic conjunctivitis at 15 minutes and 16 hours after instillation versus placebo and olopatadine 0.1%

PURPOSE To evaluate the effectiveness of alcaftadine 0.05%, 0.1%, and 0.25% ophthalmic solutions in treating the signs and symptoms of allergic conjunctivitis when compared with olopatadine hydrochloride 0.1% and placebo using the conjunctival allergen challenge (CAC) model. METHODS One hundred and seventy subjects were randomized and 164 subjects completed all visits. CAC was performed to de...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:

دوره 8  شماره 

صفحات  -

تاریخ انتشار 2015